Atlas Trials

Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer

Clinical trial NCT00466232 · COMPLETED

Trial details

NCT number
NCT00466232
Sponsor
HealthPartners Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Small Cell CarcinomaLung Cancer
Start date
2007-04-01
Primary completion
2009-12-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.